| 1 | [SID17389526] | Active | Potency | 0.3162 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus: Cytotoxicity [AID931, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus: Cytotoxicity | | AID | 931 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 2 | [SID17389526] | Active | Potency | 1.4382 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 1.4382 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 3 | [SID17389526] | Active | Potency | 1.5849 | Cell Viability - LYMP1-003 - Assay at 40 hr [AID964, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | Cell Viability - LYMP1-003 - Assay at 40 hr | | AID | 964 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID17389526] | Active | Potency | 1.9953 | Cell Viability - LYMP1-002 - Assay at 40 hr [AID994, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | Cell Viability - LYMP1-002 - Assay at 40 hr | | AID | 994 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID17389526] | Active | Potency | 1.9953 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus [AID910, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus | | AID | 910 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 6 | [SID17389526] | Active | Potency | 3.1623 | Cell Viability - LYMP2-025 [AID976, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Cell Viability - LYMP2-025 | | AID | 976 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17389526] | Active | Potency | 3.1623 | Cell Viability - LYMP2-008 [AID980, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | Cell Viability - LYMP2-008 | | AID | 980 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID17389526] | Active | Potency | 3.9781 | S16 Schwann cell PMP22 intronic element beta-lactamase assay [AID624044, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 3.9781 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element beta-lactamase assay | | AID | 624044 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 9 | [SID17389526] | Active | Potency | 5.0119 | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus [AID930, Type: confirmatory] | hemoglobin subunit beta [Homo sapiens] [gi:4504349] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus | | AID | 930 | | BioAssay type | confirmatory | | Target | hemoglobin subunit beta [Homo sapiens] [gi:4504349] | | PubMed | | | Data Table |  |
|
| 10 | [SID17389526] | Active | Potency | 6.3096 | Cell Viability - LYMP2-003 [AID965, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Cell Viability - LYMP2-003 | | AID | 965 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID17389526] | Active | Potency | 7.0795 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 12 | [SID17389526] | Active | Potency | 7.0795 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 13 | [SID17389526] | Active | Potency | 7.0795 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 14 | [SID17389526] | Active | Potency | 7.0795 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 15 | [SID17389526] | Active | Potency | 7.5686 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.5686 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17389526] | Active | Potency | 7.9433 | Cell Viability - LYMP2-004 [AID966, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-004 | | AID | 966 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID17389526] | Active | Potency | 7.9433 | Cell Viability - LYMP2-012 [AID982, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-012 | | AID | 982 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID17389526] | Active | Potency | 7.9433 | Cell Viability - LYMP2-018 [AID985, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-018 | | AID | 985 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID17389526] | Active | Potency | 10 | Cell Viability - LYMP2-020 [AID986, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-020 | | AID | 986 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID17389526] | Active | Potency | 10 | Cell Viability - LYMP2-023 [AID975, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-023 | | AID | 975 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID17389526] | Active | Potency | 10 | Cell Viability - LYMP2-019 [AID973, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-019 | | AID | 973 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID17389526] | Active | Potency | 10 | Cell Viability - LYMP1-002 - Assay at 24 hr [AID993, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP1-002 - Assay at 24 hr | | AID | 993 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-017 [AID972, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-017 | | AID | 972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-022 [AID987, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-022 | | AID | 987 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-024 [AID988, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-024 | | AID | 988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-026 [AID989, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-026 | | AID | 989 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-010 [AID981, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-010 | | AID | 981 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP2-005 [AID967, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-005 | | AID | 967 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID17389526] | Active | Potency | 12.5893 | Cell Viability - LYMP1-002 - Assay at 16 hr [AID948, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP1-002 - Assay at 16 hr | | AID | 948 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID17389526] | Active | Potency | 15.8489 | Cell Viability - LYMP2-009 [AID968, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Cell Viability - LYMP2-009 | | AID | 968 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID17389526] | Active | Potency | 15.8489 | Cell Viability - LYMP2-014 [AID983, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Cell Viability - LYMP2-014 | | AID | 983 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17389526] | Active | Potency | 15.8489 | Cell Viability - LYMP2-021 [AID974, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Cell Viability - LYMP2-021 | | AID | 974 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID17389526] | Active | Potency | 15.8489 | Cell Viability - LYMP2-007 [AID979, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Cell Viability - LYMP2-007 | | AID | 979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID17389526] | Active | Potency | 19.9526 | Cell Viability - LYMP2-011 [AID969, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | Cell Viability - LYMP2-011 | | AID | 969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID17389526] | Active | Potency | 19.9526 | Cell Viability - LYMP2-013 [AID970, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | Cell Viability - LYMP2-013 | | AID | 970 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID17389526] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 37 | [SID17389526] | Active | Potency | 33.4915 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 33.4915 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 38 | [SID17389526] | Active | Potency | 33.4915 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 33.4915 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 39 | [SID17389526] | Active | Potency | 33.4915 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 33.4915 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 40 | [SID17389526] | Active | Potency | 33.4915 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 33.4915 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 41 | [SID17389526] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389526] | Active | Potency | 66.8242 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389526] | Active | Potency | 66.8242 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 44 | [SID17389526] | Active | Potency | 66.8242 | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory] | interleukin 8 [Homo sapiens] [gi:186368] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | Potency | 66.8242 [uM] | | BioAssay | qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion | | AID | 651758 | | BioAssay type | confirmatory | | Target | interleukin 8 [Homo sapiens] [gi:186368] | | PubMed | | | Data Table |  |
|
| 45 | [SID17389526] | Active | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_1, Type: other] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID17389526] | Active | | | Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_73, Type: other] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | Cell Viability Profiling of Human Lymphoblast Cell Lines | | AID | 588812 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID17389526] | Active | | | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_27, Type: other] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines | | AID | 588813 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID17389526] | Active | | | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_39, Type: other] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines | | AID | 588813 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID17389526] | Active | | | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_40, Type: other] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines | | AID | 588813 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID17389526] | Active | | | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_41, Type: other] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17389526 | | CID | 5284626 | | Outcome | Active | | BioAssay | Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines | | AID | 588813 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|